Literature DB >> 24068830

Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus μ-opiate receptor dependent mechanisms.

Tasha Ahmad1, Nicole M Lauzon, Xavier de Jaeger, Steven R Laviolette.   

Abstract

Cannabinoid, dopamine (DA), and opiate receptor pathways play integrative roles in emotional learning, associative memory, and sensory perception. Modulation of cannabinoid CB1 receptor transmission within the medial prefrontal cortex (mPFC) regulates the emotional valence of both rewarding and aversive experiences. Furthermore, CB1 receptor substrates functionally interact with opiate-related motivational processing circuits, particularly in the context of reward-related learning and memory. Considerable evidence demonstrates functional interactions between CB1 and DA signaling pathways during the processing of motivationally salient information. However, the role of mPFC CB1 receptor transmission in the modulation of behavioral opiate-reward processing is not currently known. Using an unbiased conditioned place preference paradigm with rats, we examined the role of intra-mPFC CB1 transmission during opiate reward learning. We report that activation or inhibition of CB1 transmission within the prelimbic cortical (PLC) division of the mPFC bidirectionally regulates the motivational valence of opiates; whereas CB1 activation switched morphine reward signaling into an aversive stimulus, blockade of CB1 transmission potentiated the rewarding properties of normally sub-reward threshold conditioning doses of morphine. Both of these effects were dependent upon DA transmission as systemic blockade of DAergic transmission prevented CB1-dependent modulation of morphine reward and aversion behaviors. We further report that CB1-mediated intra-PLC opiate motivational signaling is mediated through a μ-opiate receptor-dependent reward pathway, or a κ-opiate receptor-dependent aversion pathway, directly within the ventral tegmental area. Our results provide evidence for a novel CB1-mediated motivational valence switching mechanism within the PLC, controlling dissociable subcortical reward and aversion pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24068830      PMCID: PMC6618460          DOI: 10.1523/JNEUROSCI.1686-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Opioids excite dopamine neurons by hyperpolarization of local interneurons.

Authors:  S W Johnson; R A North
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

2.  Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.

Authors:  I Katona; E A Rancz; L Acsady; C Ledent; K Mackie; N Hajos; T F Freund
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

3.  Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.

Authors:  D B Carr; S R Sesack
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.

Authors:  Marco Pistis; Luca Ferraro; Luigi Pira; Giovanna Flore; Sergio Tanganelli; Gian Luigi Gessa; Paola Devoto
Journal:  Brain Res       Date:  2002-09-06       Impact factor: 3.252

5.  Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation.

Authors:  M Pistis; G Porcu; M Melis; M Diana; G L Gessa
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

Review 6.  The neurobiology of opiate reinforcement.

Authors:  T S Shippenberg; G I Elmer
Journal:  Crit Rev Neurobiol       Date:  1998

7.  Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons.

Authors:  N Auclair; S Otani; P Soubrie; F Crepel
Journal:  J Neurophysiol       Date:  2000-06       Impact factor: 2.714

8.  GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex.

Authors:  D B Carr; S R Sesack
Journal:  Synapse       Date:  2000-11       Impact factor: 2.562

Review 9.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 10.  Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia.

Authors:  Susan R Sesack; David B Carr
Journal:  Physiol Behav       Date:  2002-12
View more
  19 in total

Review 1.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

2.  The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System.

Authors:  Anthony L Berger; Angela M Henricks; Janelle M Lugo; Hayden R Wright; Collin R Warrick; Martin A Sticht; Maria Morena; Itziar Bonilla; Sarah A Laredo; Rebecca M Craft; Loren H Parsons; Pedro R Grandes; Cecilia J Hillard; Matthew N Hill; Ryan J McLaughlin
Journal:  Biol Psychiatry       Date:  2018-05-08       Impact factor: 13.382

3.  Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.

Authors:  Tasha Ahmad; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-07-01       Impact factor: 4.530

4.  Cannabinoid transmission in the prefrontal cortex bi-phasically controls emotional memory formation via functional interactions with the ventral tegmental area.

Authors:  Brittany Draycott; Michael Loureiro; Tasha Ahmad; Huibing Tan; Jordan Zunder; Steven R Laviolette
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

5.  Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.

Authors:  Esmaeal Tamaddonfard; Amir Erfanparast; Reza Salighedar; Sina Tamaddonfard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-22       Impact factor: 3.000

Review 6.  Interaction of Cannabis Use and Aging: From Molecule to Mind.

Authors:  Hye Bin Yoo; Jennifer DiMuzio; Francesca M Filbey
Journal:  J Dual Diagn       Date:  2019-09-30

7.  The Role of Cholinergic Midbrain Neurons in Startle and Prepulse Inhibition.

Authors:  Erin Azzopardi; Andrea G Louttit; Cleusa DeOliveira; Steven R Laviolette; Susanne Schmid
Journal:  J Neurosci       Date:  2018-08-31       Impact factor: 6.167

Review 8.  Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology.

Authors:  Roger Hudson; Walter Rushlow; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-10-24       Impact factor: 4.530

9.  NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling.

Authors:  Huibing Tan; Laura G Rosen; Garye A Ng; Walter J Rushlow; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2014-05-29       Impact factor: 4.530

10.  Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.

Authors:  Sam Z Bacharach; Helen M Nasser; Natalie E Zlebnik; Hannah M Dantrassy; Daniel E Kochli; Utsav Gyawali; Joseph F Cheer; Donna J Calu
Journal:  Psychopharmacology (Berl)       Date:  2018-08-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.